📜硫氰酸铵,2,6-二氨基吡啶 以 甲醇 用作溶剂,化学反应 1.0H,以68%的收率获得2,6-二氨基-3,5-二硫氰基吡啶 参考文献:Resonance-Stabilized 1,2,3-Dithiazolo-1,2,3-Dithiazolyls As Neutral π-Radical Conductors 标题:Resonance-Stabilized 1,2,3-Dithiazolo-1,2,3-Dithiazolyls As Neutral π-Radical Conductors 摘要:Alkylation Of The Zwitterionic Heterocycle 8-Chloro-Bis[1,2,3]Dithiazolo[4,5-B:5',4'-E]Pyridine (Cibp) With Alkyl Triflates Affords 8-Chloro-4-Alkyl-4H-Bis[1,2,3]Dithiazolo[4,5-B:5',4'-E]Pyridin-2-Ium Triflates [cibpr]-[otf] (R = Me,Et,Pr). Reduction Of These Salts With Decamethylferrocene Affords The Corresponding Cibpr Radicals As Thermally Stable Crystalline Solids. The Radicals Have Been Characterized In Solution By Cyclic Voltammetry And Epr Spectroscopy. Measured Electrochemical Cell Potentials And Computed (B3Lyp/631 G**) Gas-Phase Disproportionation Enthalpies Are Consistent With A Low On-Site Coulombic Barrier U To Charge Transfer In The Solid State. The Crystal Structures Of Cibpr (R = Me,Et,Pr) Have Been Determined By X-Ray Crystallography (At 293 K). All Three Structures Consist Of Slipped Pi-Stacks Of Undimerized Radicals,With Many Close Intermolecular S...S Contacts. Cibpme Undergoes A Phase Transition At 93 K To A Slightly Modified Slipped G-Stack Arrangement,The Structure Of Which Has Also Been Established Crystallographically (At 25 K). Variable-Temperature Magnetic And Conductivity Measurements Have Been Performed,And The Results Interpreted In Light Of Extended Huckel Band Calculations. The Room-Temperature Conductivities Of Cibpr Systems (Sigma(Rt) Approximate To 10(-5) To 10(-6) S Cm(-1)),As Well As The Weak 1 D Ferromagnetism Exhibited By Cibpme,Are Interpreted In Terms Of Weak Intermolecular Overlap Along The Pi-Stacks. The Latter Is Caused By Slippage Of The Molecular Plates,A Feature Necessitated By The Steric Size Of The R And Cl Groups On The Pyridine Ring. Doi:10.1021/ja026118S
1: Wu J, Liu C, Wang T, Liu H, Wei B. Deubiquitinase inhibitor PR-619 potentiates colon cancer immunotherapy by inducing ferroptosis. Immunology. 2023 Nov;170(3):439-451. doi: 10.1111/imm.13683. Epub 2023 Aug 1. 31(16):1134-1141. doi: 10.1097/WNR.0000000000001522. 96(5):562-572. doi: 10.1124/mol.119.117390. Epub 2019 Sep 12. 4: Hsu FS, Lin WC, Kuo KL, Chiu YL, Hsu CH, Liao SM, Dong JR, Liu SH, Chang SC, Yang SP, Chen YT, Chang RJ, Huang KH. PR-619, a General Inhibitor of Deubiquitylating Enzymes, Diminishes Cisplatin Resistance in Urothelial Carcinoma Cells through the Suppression of c-Myc: An In Vitro and In Vivo Study. Int J Mol Sci. 2021 Oct 28;22(21):11706. doi: 10.3390/ijms222111706. 5: Hu X, Zhang J, Ma H, Lian W, Song W, Du C, Chen S, Wang D, Wei J, Lu Q. The broad-spectrum deubiquitinating enzyme inhibitor PR-619 protects retinal ganglion cell and augments parkin-mediated mitophagy in experimental glaucoma. Sci Rep. 2024 Oct 21;14(1):24654. doi: 10.1038/s41598-024-75562-3.
合成参考文献
参考文献:10.1101/2020.12.16.422677 摘要:Kuzikov M, Costanzi E, Reinshagen J, Esposito F, Vangeel L, Wolf M, Ellinger B, Claussen C, Geisslinger G, Corona A, Iaconis D, Talarico C, Manelfi C, Cannalire R, Rossetti G, Gossen J, Albani S, Musiani F, Herzog K, Ye Y, Giabbai B, Demitri N, Jochmans D, De Jonghe S, Rymenants J, Summa V, Tramontano E, Beccari AR, Leyssen P, Storici P, Neyts J, Gribbon P, Zaliani A. Identification of inhibitors of SARS-CoV-2 3CL-Pro enzymatic activity using a small molecule in-vitro repurposing screen. (). doi: 10.1101/2020.12.16.422677. 参考文献:10.1124/mol.119.115964 摘要:Lee TD, Lee OW, Brimacombe KR, Chen L, Guha R, Lusvarghi S, Tebase BG, Klumpp-Thomas C, Robey RW, Ambudkar SV, Shen M, Gottesman MM, Hall MD. A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein. Molecular Pharmacology. 2019 Nov;96(5):629–40. doi: 10.1124/mol.119.115964.